Back
Protagonist Therapeutics Vs. Metropolitan Bank Holding Industry Stock Comparison
Buy
71
PTGX
Protagonist Therapeutics
Last Price:
31.72
Seasonality Move:
18.27%
Buy
60
MCB
Metropolitan Bank Holding
Last Price:
44.94
Seasonality Move:
29%
Buy
71
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $31.71. The Score for PTGX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Metropolitan Bank Holding (MCB)
is a Buy
Is Metropolitan Bank Holding a Buy, Sell or Hold?
- The current Metropolitan Bank Holding [MCB] share price is $44.97. The Score for MCB is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- MCB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $31.71
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight selling pressure.
MCB Stock Price Chart
What is Metropolitan Bank Holding's stock price today?
-
The Metropolitan Bank Holding share price today is $44.97
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MCB is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.29 | Buy |
| Relative Strength Index (14 RSI): | 69.31 | Buy |
| Chaikin Money Flow: | -274585 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.15 - 30.13) | Buy |
| Bollinger Bands (100): | (24.95 - 29.69) | Buy |
MCB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.48 | Buy |
| Relative Strength Index (14 RSI): | 65.16 | Buy |
| Chaikin Money Flow: | 86730 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.8 - 44.42) | Buy |
| Bollinger Bands (100): | (37.07 - 47.59) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.97 | Buy |
| 20-day SMA: | 28.04 | Buy |
| 50-day SMA: | 27.85 | Buy |
| 200-day SMA: | 22.6 | Buy |
| 8-day EMA: | 30.72 | Buy |
| 20-day EMA: | 29.1 | Buy |
| 50-day EMA: | 28 | Buy |
| 200-day EMA: | 24.33 | Buy |
MCB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.89 | Buy |
| 20-day SMA: | 42.67 | Buy |
| 50-day SMA: | 39.17 | Buy |
| 200-day SMA: | 40.83 | Buy |
| 8-day EMA: | 43.93 | Buy |
| 20-day EMA: | 42.52 | Buy |
| 50-day EMA: | 41.09 | Buy |
| 200-day EMA: | 41.88 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $3.70 per share, and a decrease next year of $1.31 per share.
Metropolitan Bank Holding Earnings Growth & MCB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.16 per share, a decrease this year of $0.41 per share, and an increase next year of $0.92 per share.
Protagonist Therapeutics Technical Analysis
| May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Metropolitan Bank Holding Technical Analysis
| May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||